Lifeboat Foundation

NASA will provide live coverage of prelaunch and launch activities for the National Oceanic and Atmospheric Administration’s (NOAA) GOES-U (Geostationary Operational Environmental Satellite U) mission. The two-hour launch window opens at 5:16 p.m. EDT Tuesday, June 25, for the satellite’s launch on a SpaceX Falcon Heavy rocket from Launch Complex 39A at NASA’s Kennedy Space Center in Florida.

The GOES-U satellite, the final addition to GOES-R series, will help to prepare for two kinds of weather — Earth and space weather. The GOES satellites serve a critical role in providing continuous coverage of the Western Hemisphere, including monitoring tropical systems in the eastern Pacific and Atlantic oceans. This continuous monitoring aids scientists and forecasters in issuing timely warnings and forecasts to help protect the one billion people who live and work in the Americas. Additionally, GOES-U carries a new compact coronagraph that will image the outer layer of the Sun’s atmosphere to detect and characterize coronal mass ejections.

The deadline for media accreditation for in-person coverage of this launch has passed. NASA’s media credentialing policy is available online. For questions about media accreditation, please email: [email protected].

Liftoff of the ‘No Time Toulouse’ mission took place at 2:13 p.m. ET on Thursday (June 20).

Spin-orbit torque effects involve the transfer of angular momentum between a spin current and a magnetic layer mediated by the exchange interaction between conduction and localized electron.

Measuring these effects in magnetic materials continues to be a very active area of interest in spintronics…

Electrons have an intrinsic angular momentum, the so-called spin, which means that they can align themselves along a magnetic field, much like a compass needle. In addition to the electric charge of electrons, which determines their behavior in electronic circuits, their spin is increasingly used for storing and processing data.

Continue reading “An alternative way to manipulate quantum states” »

Michael Galkin and Michael Bronstein argue that the era of Graph FMs has already begun and provide a few examples.

Table of Contents.

1.

Continue reading “Foundation Models in Graph & Geometric Deep Learning” »

Dr. Ana Diaz Artiles: “When we’re upright, a large part of our fluids are stored in our legs, but in microgravity we get a redistribution of fluids into the upper body.”

What physiological effects can extended periods of microgravity have on the human eye? This is what a recent study published in npj Microgravity hopes to address as a team of researchers investigated how the shifting of fluids under microgravity conditions could lead to eye vessel alterations. This study holds the potential to help space agencies, researchers, and the public better understand the short-and long-term physiological effects of microgravity, specifically with more humans traveling beyond Earth’s gravity on commercial spaceflights.

“When we experience microgravity conditions, we see changes in the cardiovascular system because gravity is not pulling down all these fluids as it typically does on Earth when we are in an upright position,” said Dr. Ana Diaz Artiles, who is an assistant professor in the Department of Aerospace Engineering at Texas A&M University and a co-author on the study. “When we’re upright, a large part of our fluids are stored in our legs, but in microgravity we get a redistribution of fluids into the upper body.”

Continue reading “Impact of Space Flight on Human Health: A Focus on the Eye” »

Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets multiple molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors use to survive.

In a clinical trial at NIH’s National Cancer Institute (NCI), researchers tested the combination of venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (called ViPOR) in 50 patients with DLBCL, the most common type of lymphoma. The treatment shrank tumors substantially in 26 of 48 (54%) evaluable patients, with 18 (38%) of those patients’ tumors disappearing entirely, known as a complete response. At two years, 36% of all patients were alive and 34% were free of disease. These benefits were seen mainly in people with two specific subtypes of DLBCL.

The findings were published June 20, 2024, in the New England Journal of Medicine.

The breakthrough clears the way for smarter, more agile nanotech.

The model is already available for free on http://claude.ai and the Claude iOS app.

Claude 3.5 Sonnet is their our strongest vision model.

Sonnet…

Continue reading “Claude: Anthropic just released Claude 3.5, a new model that surpasses GPT-4o on multiple benchmarks while being 2x faster and 80% cheaper than Claude 3 Opus” »

Dr. Ben Murnane has published an Opinion piece in FEE, the Foundation for Economic Education, a major US think thank. The essay covers #transhumanism and the new biography Transhuman Citizen, out in 10 days.

It’s telling that with the rise of AI the first instinct of many politicians is to regulate it.